| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $0.99 (Beat by $0.02) |
| EPS GAAP Actual | $0.99 (Beat by $0.02) |
| Revenue Actual | $15.004B |
| Revenue Surprise | Beat by $15004M |
| Announce Date | 02/25/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.81 |
| EPS GAAP Estimate | $0.81 |
| Revenue Estimate | $14.07B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 6.81617 | 11.12 | 6.51011 | 7.49793 | 4 |
| Dec 2028 | 5.71786 | 13.26 | 5.54992 | 5.91323 | 3 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0 | -0.84 | 15.004B | -99.15% | -206M |
| FQ1 2025 (Mar 2025) | 1.08 | 0.39 | 13.628B | -113.49% | -782M |
| FQ4 2024 (Dec 2024) | 3.26 | 2.5 | 29.8655B | -0.56% | 14525.5M |
| FQ3 2024 (Sep 2024) | 1.03 | 1.03 | 15.046B | -3.51% | 15046M |
| FQ2 2024 (Jun 2024) | 1.28 | 1.28 | 29.88B | 49.4% | 29880M |
| FQ1 2024 (Mar 2024) | 1.1 | 1.1 | 29.094B | 51.15% | 29094M |
| FQ4 2023 (Dec 2023) | 1.64 | 1.64 | 30.0324B | 51.16% | 30032.4M |
| FQ3 2023 (Sep 2023) | 0.73 | 0.73 | 15.574B | 100% | 15574M |
FQ4 Announce Date
02/25/2026 (Pre-Market)
Consensus EPS Estimates
0.81
Consensus Revenue Estimates
14.07B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Feb 2027) | 0.9 | -- | 0.87 | 0.92 | 2 |
| FQ4 2026 (Nov 2026) | 0.95 | -- | 0.89 | 1.09 | 4 |
| FQ3 2026 (Aug 2026) | 0.97 | -- | 0.93 | 1.02 | 4 |
| FQ2 2026 (May 2026) | 0.94686 | -- | 0.93058 | 0.96 | 3 |
| FQ1 2026 (Feb 2026) | 0.81 | -33.33 | 0.78 | 0.84 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Feb 2027) | 14.67B | -- | 14.63B | 14.71B | 2 |
| FQ4 2026 (Nov 2026) | 15.9B | -- | 15.77B | 15.97B | 4 |
| FQ3 2026 (Aug 2026) | 15.35B | -- | 15.25B | 15.45B | 5 |
| FQ2 2026 (May 2026) | 15.3B | 1.92 | 15.12B | 15.51B | 6 |
| FQ1 2026 (Feb 2026) | 14.07B | 3.14 | 13.43B | 14.96B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.84 | 0 | -0.84 | -INF% |
| FQ1 2025 (Mar 2025) | 0.69 | 1.08 | 0.39 | 36.11% |
| FQ4 2024 (Dec 2024) | 0.76 | 3.26 | 2.5 | 76.69% |
| FQ3 2024 (Sep 2024) | 1.03 | 1.03 | 100% | |
| FQ2 2024 (Jun 2024) | 1.28 | 1.28 | 100% | |
| FQ1 2024 (Mar 2024) | 1.1 | 1.1 | 100% | |
| FQ4 2023 (Dec 2023) | 1.64 | 1.64 | 100% | |
| FQ3 2023 (Sep 2023) | 0.73 | 0.73 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $15.21B | $15B | $-206M | -1.37% |
| FQ1 2025 (Mar 2025) | $14.41B | $13.63B | $-782M | -5.74% |
| FQ4 2024 (Dec 2024) | $15.34B | $29.87B | $14525.5M | 48.64% |
| FQ3 2024 (Sep 2024) | $0B | $15.05B | $15046M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $29.88B | $29880M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $29.09B | $29094M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $30.03B | $30032.4M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $15.57B | $15574M | 100% |